KTTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Pasithea Therapeutics Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.41−0.01 (-1.83%)
Close on Oct 19, 2026
- Market cap
- $13.23M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Pasithea Therapeutics has not reported a dividend
No dividend per share appears in Pasithea Therapeutics's annual filings since fiscal 2020.